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Abstract 
Background: Malaria is one of the leading causes of morbidity and mortality in African countries. It is one of the 
leading causes of hospital visits and hospitalization in pediatric wards for children under 5 years old. Interestingly 
however, the economic burden of this disease remains unknown in these endemic countries including Gabon. The 
purpose of this study is to assess the direct hospital cost for the management of malaria in children under 5 years old 
at the Libreville University Hospital Centre (CHUL, Centre Hospitalier Universitaire de Libreville) in Gabon.
Methods: This research work is a retrospective study using a comprehensive review of medical records of patients 
seen at the CHUL over a two‑year period extending from January 2018 through December 2019. The study focused 
on children under 5 years old, admitted for malaria in the paediatric ward of the CHUL. The analysis targeted specifi‑
cally direct hospital costs, which excluded salary and wages of health care workers. The monetary currency used in 
this study was the CFA francs, as that currency is the one used in Central Africa (as reference, 1 Euro = 656 CFA francs).
Results: For the set timeframe, 778 patient records matched the study criteria. Thus, out of 778 admitted patients, 
58.4% were male while 41.5% were female. Overall, the average age was 13.2 months (± 13.8 months). The total cost 
incurred by the hospital for the management of these 778 malaria patients was 94,922,925 CFA francs (144,699.58 
€), for an average expense per patient topping at 122,008 CFA francs (185.99 €). The highest expenditure items were 
hospitalizations (44,200,000 CFA francs, 67,378.1 €), followed by drugs (26,394,425 CFA francs, 40,235.4 €) and biomedi‑
cal examinations (14,036,000 CFA francs, 21,396.34 €).
Conclusion: The financial burden for managing malaria in the paediatric ward seems to be very high, not only for the 
hospital, but also for families in spite of the government medical insurance coverage in some cases. These findings 
bring new insights as to the urgency to develop policies that foster preventive initiatives over curative approaches in 
the management of malaria in children in endemic countries.
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Background
Malaria has remained a burden for African countries for 
years. The World Health Organization [1], in its 2018 
malaria progress report, estimated the number of cases 
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2019, this number increased to 229 million of the malaria 
cases, for an estimated total of 409,000 deaths, accord-
ing to the WHO statement [2]. The world records about 
one million deaths each year due to malaria and among 
which 91% are reported in Africa, with 85% of that toll 
representing children under 5 years [2]. In Gabon, in 
2019 malaria ranked first among the top ten causes of 
morbidity and mortality [3]. All ages combined; the total 
number of malaria cases recorded was 124,478 cases. 
For the same period, the number of cases of children 
aged 0–5  years was estimated at 41,087 cases in health 
care facilities. In spite of the fact that deaths are under-
reported, 120 deaths were nevertheless recorded for the 
year 2019 in the main health care facilities in the country 
[2].
Management of this disease involves significant logis-
tics for hospitals and substantial financial resources for 
the government, patients or families of patients. In its 
financial report for the elimination of malaria, the WHO 
declared a funding of US$ 3 billion in 2019, a fund con-
sidered insufficient [2]. In countries where malaria 
remains endemic, very few studies have been conducted 
to evaluate the direct cost of treating this disease [4]. At 
this point in time, there is no known studies evaluating 
the economic burden of malaria management in Gabon, 
which is one of the African countries with a high inci-
dence of malaria.
Thus, the aim of this study was to assess the direct hos-
pital cost of the management of malaria in children under 
5 years old at the Libreville University Hospital Centre 
(CHUL, Centre Hospitalier Universitaire de Libreville) in 
Gabon. The findings of this study could provide a basis 
for further investigation on the cost-effectiveness of pre-
vention programmes and eventually to the development 
of prevention policies that could be beneficial to govern-
ments and families of patients in endemic regions.
There is very little data on the financial burden of 
malaria on Gabon’s health system and households. A 
few studies have been conducted in African countries, 
but not enough to clearly assess the economic burden of 
the endemic [5–7]. This study modestly aims to help fill 
this gap. The results will be discussed and compared with 
those of other studies conducted to assess the burden of 
this disease.
Methods
The study took place in the paediatric department of the 
Centre Hospitalier Universitaire de Libreville (CHUL) 
in Gabon. In Gabon, the CHUL was a hospital of choice 
to conduct this study because in one hand, that hospital 
has the largest paediatric ward in the country, on another 
hand, the facility is adequately equipped to care for chil-
dren and very importantly, to keep accurate records of 
medical procedures of patients admitted in the facil-
ity. Thus, a retrospective study was performed based 
on the review of patient records over a two-year period 
from January 2018 to December 2019. The retrospec-
tive study started in 2018 because the implementation 
of the National Health Information System (SNIS, Sys-
tème National d’Information Sanitaire) did not take place 
in Gabon before then. The SNIS helped Gabon create a 
centralized health information system that allowed the 
CHUL to store and keep accurate information of patients 
seen in the facility. Hence, no accurate health informa-
tion could be obtained before that year. So, data were 
collected retrospectively on the basis of patient records 
archived in the paediatric department on one hand and 
using the nomenclature of procedures and the list of 
drugs prescribed on the other hand for the cost of pro-
cedures. All files available onsite were taken into account.
The first step of this study was to collect clinical and 
biological parameters necessary for the diagnosis of 
malaria at admission using a pre-established survey 
form. This was followed by examining and sorting the 
files according to the target age of admitted patients (0 
to 5 years). After the files were examined, the form was 
filled out. More specifically, the socio-demographic data 
of children, the examinations prescribed to diagnose 
and monitor evolution of the disease, and medications 
administered during hospitalization were recorded on 
the form. The second step consisted in determining the 
unit costs of all the procedures executed and the costs of 
hospital stays.
The monetary assessment of the pharmaceutical prod-
ucts used (drugs and medical devices) was made on 
the basis of the repository of medicines covered by the 
National Health Insurance and Social Guarantee Fund [8, 
9]. The National Health Insurance and Social Guarantee 
Fund (CNAMGS) is a government-owned and govern-
ment-managed compulsory health insurance and social 
guarantee entity designed to assist the Gabonese popu-
lation with their health expenses. It is the only govern-
ment insurance that covers all Gabonese citizens who are 
duly registered and maintain their membership in good 
standing. It covers health care prescriptions and proce-
dures according to a percentage established by the gov-
ernment. Typically, the percentage of coverage varies 
between 50% and 80% depending on the medical proce-
dure, which could be a clinical examination, a laboratory 
test, an imaging examination, and/or a drug prescription. 
The rest of the balance is covered by the patient and/or 
their family. In health care facilities, that balance due by 
the patient is called moderator ticket or co-payment. In 
this study, the costs for medical products not reimbursed 
by the government insurance were obtained in pharma-
cies. Although private insurances exist in Gabon, there is 
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no complementarity between them and the government 
health insurance.
Out-of-pocket expenses for insured patients or co-pay-
ments were evaluated in relation to the level of coverages 
set by the health insurance for different health proce-
dures and medications prescribed.
The public health care is set in Gabon such that public 
hospitals are completely supported by the government. In 
other words, the costs for the maintenance and operation 
of the premises are covered by the government budget 
regardless of the frequency use by patients. Furthermore, 
salaries and wages of health professionals and allies are 
paid by the government and do not involve in any way a 
contribution from the patients. Gabonese health work-
ers are civil servants whose salaries and wages are fixed 
regardless of the number of patients seen or medical 
procedures executed. Therefore, the costs pertaining to 
the maintenance, management of the health care facility 
and salary and wages were not included as these are all 
considered indirect cost. However, hospitalization costs 
which included bed occupancy, food and beverages con-
sumed by patients were all part of direct costs associated 
with malaria management.
The study performed here was primarily observational, 
retrospective, and based exclusively on medical records. 
It was non-invasive and carried no physical, mental, nor 
emotional risk to the patient. It did not involve human 
or animal experimentation. Therefore, this study was 
exempt from ethics approval as this is the procedure 
currently applied in Gabon. Nevertheless, in compli-
ance with the research protocols in Gabon, two research 
authorizations were obtained for the collection of infor-
mation on medical records. One was provided by the 
General Secretary of the Ministry of Health (authori-
zation N°002395/MS/SG/PSNIS) and the second one 
was issued by the Chief Executive Officer of the CHUL 
(authorization N°0078/MS/CHUL/DG/DGA).
All data were recorded in a database created using an 
Excel spreadsheet. Data collected and compiled in the 
database were analysed with the R software (version 
3.6.1). Quantitative variables were expressed in means 
with their standard deviation while qualitative data were 
expressed in percentage values.
Results
The study involved 778 patients who were admitted to 
the paediatric ward during the designated period. Analy-
sis of all cases documented revealed that 58.5% were male 
and 41.5% female. Furthermore, analysis of data showed 
that the overall average age of patients was 13.2 months 
(± 13.8 months). The median age in the female group 
was 7 months of age while in the male group, it was 9 
months. Also, the screening of patient files showed that 
more than half of them (58.5%) had an age range that var-
ied between 1 month and 12 months old and that 51.7% 
(402) of patients did not have any health insurance cov-
erage. 488 patients exhibited complications among which 
28% suffered of anaemia and 16% had prostration. Table 1 
summarizes the socio-demographic characteristics and 
complications recorded among patients.
There was no significant variation in average expendi-
ture by socio-demographic characteristics, between age 
groups or even by gender. The age group with the high-
est average cost was the 24 to 36 month-old group which 
spent an average of 122,975 CFA francs (187 €), followed 
by the 12 to 24 month-old group with an average expend-
iture of 122,711 CFA francs (187 €).
By gender, expenses incurred by male patients were 
higher (125,253 CFA francs, 191 €) average than those 
of female patients (117,438 CFA francs, 179 €). The age 
group with the highest average out of pocket expense, 
meaning the remaining balance after insurance cover-
age, was the 1 to 12 month-old group which showed a 
remaining balance of 28,203 CFA francs (43 €) due by the 
patient, followed by the 24 to 36 month-old group with a 
remaining balance of 27,983 CFA francs (42 €) (Table 2).
The total expenditure for the care of the study popu-
lation was 94,922,925 CFA francs (144,699 €) which rep-
resented an average of 122,008 CFA francs (186 €) per 
patient. Uninsured patients incurred an average total 
expenditure of 118,480 CFA francs (180 €). After insur-
ance coverage of expenses, the remaining balance due by 
insured patients was found to be 27,558 CFA francs (42 
€) per patient from a total pre-insurance coverage cost 
of 10,361,901 CFA francs (15,795 €). Health insurance 
reimbursement to healthcare service facilities for patient 
care were determined to cost of 36,931,352 CFA francs 
(56,298 €) overall.
Of the overall cost caused by malaria, the highest 
expenditure item was associated with patient hospitaliza-
tion, at an overall cost of 44,200,000 CFA francs (67,378 
€) which represented 46.56% of the total cost of malaria 
patient care during the study period. Far behind hospital-
ization cost was the cost amount associated with the pur-
chase of malaria medicines at a grand total of 26,394,425 
CFA francs (40,235 €) representing 27.8% of the total cost 
of malaria management cases for the period under study 
(Table 3).
Of the 778 malaria patient records reviewed, data 
analysis showed that 335 patients developed pulmonary 
oedema as a result of malaria-related complications. The 
average cost associated with the care of these particular 
patients was 137,087 CFA francs (209 €). In this particu-
lar instance, there was no significant difference in the 
costs incurred when comparing insured and uninsured 
patients.
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Table 1 Sociodemographic characteristics and complications due to malaria at the time of admission
Characteristics Patient set N = 778 Insured patient N = 376 (48.3%) Uninsured patient 
N = 402 (51.7%)
Age in months, average (SD) 13.2 (± 13.8) 14.0 (± 15.0) 12.4 (± 12.6)
Gender, N (%)
 Male 455 (58.5) 224 (59.6) 231 (57.5)
 Female 323 (41.5) 152 (40.4) 171 (42.5)
Age range in months, N (%)
 [1–12] 489 (62.9) 235 (62.5) 254 (63.1)
 [12–24] 185 (23.9) 83 (22.1) 102 (25.4)
 [24–36] 57 (7.3) 26 (6.9) 31 (7.7)
 36–48] 33 (4.2) 23 (6.1) 10 (2.5)
 [48–60] 14 (1.8) 9 (2.4) 5 (1.2)
Complications, N (%)
 None 290 (37.3) 137 (36.4) 155 (38.5)
 Consciousness disorders 9 (1.2) 7 (1.9) 2 (0.2)
 Convulsion 62 (7.9) 24 (6.4) 38 (9.4)
 Prostration 126 (16.2) 59 (15.7) 67 16.7)
 Respiratory distress 29 (3.7) 17 (4.5) 12 (2.9)
 Jaundice 32 (4.1) 18 (4.8) 14 (3.5)
 Bleeding 5 (0.6) 5 (1.3) 0 (−)
 Anaemia 225 (28.9) 111 (29.5) 114 (28.4)
Table 2 Average costs of malaria cases by socio‑demographic characteristics
Characteristics Uninsured patients Insured patients
Total expenditure Insurance coverage Co-payment
Age in months
 [1–12] 115,686 (44,349) 129,500 (66,994) 101,297 (53,536) 28,203 (15,364)
 [12–24] 125,217 (61,178) 119,631 (58,738) 92,520 (45,093) 27,111 (18,482)
 [24–36] 116,530 (43,646) 136,530 (87,878) 102,677 (70,389) 27,983 (17,639)
 [36–48] 130,842 (66,883) 111,998 (34,680) 88,007 (27,593) 23,990 (7,499)
 [48–60] 110,357 (29,305) 106,507 (27,811) 83,795 (22,301) 22,712 (5,689)
Gender
 Male 129,851 (54,883) 129,851 (73,715) 101,596 (58,893) 28,254 (16,622)
 Female 115,354 (41,257) 119,783 (48,324) 93,252 (37,465) 26,531 (14,389)
Table 3 Average costs by expenditure item
Type of 
expenditure













Medical visit 7,780,000 (8.2) 10,000 10,000 2000 8000 10,000 [0, 0–10]
Hospitalization 44,200,000 (46.6) 53,681 60,159 12,096 48,385 56,812 [0, 0–480]
Laboratory tests 14,036,000 (14.8) 18,044 18,037 3728 14,308 18,041 [0–30, 500]
Imaging exams 2,512,500 (2.6) 2779 3710 1484 2226 3229 [0–7, 500]
Drugs 26,394,425 (27.8) 33,974 33,874 8313 25,561 33,926 [3960–177,271]
Total 94,922,925 (100.0) 118,480 125,781 27,558 98,223 122,008 [39,073–531,740]
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The malaria cases record indicated that the most com-
mon laboratory examinations performed as part of the 
diagnosis were blood smears, complete blood counts, 
blood urea nitrogen tests, and creatinine tests. Of all 
the malaria records screened during the study, 93.3% 
included blood smears as a diagnosis test, and 97% con-
tained the results of complete blood counts. Further-
more, blood urea nitrogen tests were performed in 60.4% 
of the cases analysed while creatinine tests were done in 
59.5% of the cases included in this study (Table 4).
Discussion
The purpose of this study was to assess the direct hospi-
tal cost of malaria management in children, whose ages 
ranged between 0 and 5 years old. The cost analysis was 
mainly based on costs incurred by the government health 
insurance coverage and the amount of money due to be 
paid by patients whether they were covered by health 
insurance or not. However, analysis of the costs did not 
include the compensation healthcare workers.
This study showed a cost of malaria management per 
patient of 122,008 CFA francs (186 €), meaning a total 
expenditure of 95,083,524 CFA francs (144,944 €) for a 
total of 778 malaria patients whose age varied between 
0 and 5 years. Uninsured patients registered an aver-
age expenditure four times higher than that observed 
in patients receiving health benefits from the govern-
ment insurance scheme. On average, uninsured fami-
lies spent 118,480 CFA francs (181 €) to care for their 
sick child. The expense incurred by these families was 
sadly very close to the monthly national minimum wage 
of 150,000 CFA francs (229 €), reflecting the heavy and 
costly burden an episode of malaria leading to child’s 
hospitalization for uninsured families. In fact, the 
expenses incurred by uninsured families represented 
up to 78% of the national minimum wage. Conversely, 
families receiving health coverage from the govern-
ment incurred a much lower out-of-pocket expense 
averaging 27,558 CFA francs (42 €). A closer look at 
malaria management costs for insured families shows 
that the health insurance policy covers 80% of costs, 
while insured families themselves paid only 20% of the 
cost. While this is still a great deal for insured families, 
the cost also represents a major expense for the gov-
ernment-provided health insurance coverage. Indeed, 
the government health insurance paid to healthcare 
facilities an average of 98,223 CFA francs (150 €) per 
patient, which shows the onerous cost of clinical phase 
of malaria management for the government.
While there has been little work in the literature on 
the actual cost of malaria management, with the major-
ity of studies focusing on management of clinical cases of 
malaria in adult patients, the financial burden of malaria 
is extremely high in many countries where malaria is 
endemic. This is the case, for instance, in the study 
conducted by Faye et al. [10], in which the authors per-
formed the economic evaluation of rapid diagnostic tests 
in the treatment of malaria in Ziguinchor, Senegal. The 
study involved 379 cases of malaria and included patients 
of all ages. That study reported an overall cost of clini-
cal malaria management of 299,957 CFA francs (457 €). 
The financial cost for patients was 184,500 CFA francs 
(281 €) while the government health insurance covered 
115,457 CFA francs (176 €). Although the overall cost of 
299,957 CFA francs (457 €) seems lower than the find-
ings in the present study, Faye and his colleagues con-
sidered the costs in their study to be too high given the 
lower count of their population. Interestingly however, 
the out-of-pocket expenses paid by insured patients were 
much higher in their study than in the current study, 
Table 4 Unit costs per test and average cost by test type and per patient
Type of test Number of tests (%) Unit cost Global cost Insured patients Uninsured patients
Imaging exam
 Pulmonary edema 335 (43.1) 7500 137,087 136,200 138,194
Laboratory tests
 Blood smear 726 (93.3) 3000 122,308 125,503 119,233
 Complete blood count 755 (97.0) 7500 122,516 125,883 119,332
 Blood urea nitrogen 470 (60.4) 3500 125,704 129,500 122,065
 Creatine 463 (59.5) 3500 125,339 129,595 121,316
 Transaminase 351 (45.1) 6000 126,204 127,690 124,824
 Blood glucose 242 (31.1) 3500 130,688 131,339 130,089
 Total protein 9 (1.2) 3500 114,628 116,083 113,900
 Tck 3 (0.4) 3500 75,336 59,110 83,450
 Parasitaemia 2 (0.3) 3000 76,920 76,920 –
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confirming the tremendous economic burden of clinical 
management of malaria for governments and families.
In a study published in 2005 by Forlack et  al. [11], 
which examined the cost-effectiveness of managing 
severe malaria in children in two district hospitals in 
Cameroon, the costs of managing malaria were much 
lower than those observed in this analysis. Indeed, in 
their study, the hospital cost for each episode of severe 
malaria ranged from 26,000 to 36,000 CFA francs (40 to 
55 €). Their study showed that the overall direct costs, 
which included costs incurred before and during hospi-
talization ranged from 27,000 to 39,000 CFA francs (41 to 
59 €). While the financial impact reported in Cameroon 
was much lower than that shown in this study performed 
in Gabon, the difference may be accounted for by the dif-
ference in the cost of living in the two countries which 
is much higher in Gabon than Cameroon. Thus, with a 
national minimum wage of 36,000 CFA francs (55€) in 
Cameroon, the cost of malaria management of 39,000 
CFA francs (59 €) is extremely high for families, which 
reinforces the assessment of the heavy burden expe-
rienced by populations in the management of malaria 
in healthcare facilities in both Cameroon and Gabon. 
Similarly, in their study performed in Ivory Coast, Koua-
dio et  al. [12] estimated an average direct cost per case 
of malaria around 8,725 CFA francs (13.3 €). While this 
cost appears much lower than that observed in other 
studies, including this one, it is nevertheless perceived by 
the authors as a heavy economic burden for low-income 
households living in poor neighbourhoods of Abidjan.
The highest expenditures in this study were hospitaliza-
tions and drug prescriptions which accounted for 74.4% 
of total expenses. These findings are similar to those 
reported by Couitchéré et al. [13] in Ivory Coast, where 
the report explains that the highest costs of malaria care 
are associated with paraclinical examinations, drug pre-
scriptions, and hospitalizations.
The cost of treating malaria represents a heavy burden 
for countries with high malaria prevalence. This heavy 
burden is paid by uninsured families, who sometimes 
resort to borrowing money for the care of their relatives. 
While, this study did not highlight these aspects because 
a population survey was not conducted, nevertheless, 
other studies conducted among households have high-
lighted the difficulties faced by these families. In the study 
on the financing of the management of severe malaria in 
children by households in Kinshasa, Ilunga-Ilunga et  al. 
[14] examined the financial protocol used by families to 
pay for expenses incurred during malaria episodes. They 
reported in their study that 56% of households turned to 
external financial sources, including selling goods, bor-
rowing money, and putting in pawn some valuable assets 
to care for their hospitalized children. Furthermore, 
Adhikari et  al. [15], in their study of treatment-seeking 
behaviour for febrile illnesses and its implications for 
malaria control and elimination in the Savannakhet prov-
ince in Laos, reached similar conclusions. This province 
of Laos is landlocked and poor, making it difficult for 
people to use health services due to lack of money. The 
first recourse for disease treatment in that region was 
spiritual healers, a solution considered more economical 
by these populations. The situations highlighted in these 
studies support the idea about the burden of malaria 
management in endemic countries.
The present study is not without limitations. Indeed, 
this study does not take into account the indirect costs 
related to the salaries of health professionals, patient 
transport and the loss of income of accompanying per-
sons. Health professionals are civil servants, and their 
salaries are paid by the government budget. In spite 
of multiple attempts, the research team was not able 
to obtain this information, which is inaccessible to the 
public.
Conclusion
Malaria remains one of the leading causes of morbidity 
and mortality, particularly among children. The man-
agement of complicated cases generates considerable 
expenses and is a burden for patients’ families and the 
government. The financial burden is not only heavy for 
families without social security coverage, but also for the 
government which bears the greatest part of the finan-
cial burden generated by insured patients and their fami-
lies. Indeed, in Gabon, the health insurance offered by 
the government covers up to 80% of the costs incurred 
for the management of malaria cases for qualified fam-
ilies. The results of this study show that the direct cost 
of hospital care is very high in a country where a large 
proportion of the population lives below the poverty line. 
These results highlight the urgent need to strengthen and 
develop public health policies that would favour preven-
tion as a major mean of controlling and fighting malaria, 
not only in Gabon, but also in all other endemic coun-
tries. A short-term and less costly solution could be to 
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